Results 151 to 160 of about 1,026 (172)

Bulevirtide

Reactions Weekly, 2019
openaire   +1 more source

Hepatitis delta treatment with bulevirtide in real life: a case report

International Journal of Antimicrobial Agents, 2022
Giordan, Marc-Antoine, Bengone Abogourin, Jessica Grace, Aherfi, Sarah, Allemand, Isabelle, Colson, Philippe   +4 more
openaire   +3 more sources

Immediate-Type Hypersensitivity Reaction to Bulevirtide and Successful Desensitization in a Patient With HBV/HDV-Associated Compensated Cirrhosis

Journal of Hepatology, 2022
Caroline Schwarz, David Chromy, Michael Gschwantler   +2 more
exaly  

Bulevirtide/peginterferon-α-2a

Reactions Weekly, 2022
openaire   +1 more source

Bile Acid Increase During Bulevirtide Treatment of Hepatitis D Is Not Associated With a Decline in HDV RNA

Journal of Viral Hepatitis, 2023
Kerstin Port, Benjamin Maasoumy, Christopher Andreas Dietz   +2 more
exaly  

Normalisierung der Leberwerte mit Bulevirtid

CME, 2022
openaire   +1 more source

Bulevirtide/peginterferon-alfa-2a

Reactions Weekly, 2023
openaire   +1 more source

Bulevirtide for chronic hepatitis D: phase III data

Nature Reviews Gastroenterology & Hepatology, 2023
openaire   +2 more sources

Impact of patient-related factors on the pharmacokinetics of Bulevirtide

Journal of Hepatology, 2022
Renu Singh, Parag Kumar, Rory Leisegang, Francesco Bellanti, Craig Comisar, Kishore Polireddy, Vithika Suri, Dmitry Manuilov, John F. Flaherty, Sandhya Girish   +9 more
openaire   +1 more source

Safety and Effectiveness of Up to 3 Years’ Bulevirtide Monotherapy in Patients With HDV-Related Cirrhosis

Journal of Hepatology, 2022
Alessandro Loglio, Laura Porretti, Ferruccio Ceriotti   +2 more
exaly